Skip to content
Search

Latest Stories

Submit Guest Post

India's coronavirus cases top 3.2 million

INDIA recorded more than 60,000 cases of Covid-19 for the eighth day in a row on Wednesday (26), as total cases crossed 3.2 million, data from the federal health ministry showed.

The world's second-most populous country is third behind the US and Brazil in terms of total caseload, and has recorded the world's highest single-day caseload consistently since August 7, a Reuters tally showed.


Deaths in the last 24 hours stood at 1,059, taking the total number of fatalities from the infection to 59,449. The country reported its first coronavirus infection on January 30.

The overall Covid-19 count reached 3,234,475 including 707,267 active cases.

Maharashtra has 166,239 active cases, the highest in the country followed by Andhra Pradesh with 89,932 active cases.

As many as 823,992 samples were tested on August 25 while over 37 million samples have been tested so far, according to the Indian Council of Medical Research (ICMR).

According to the health ministry, India has exponentially scaled its testing from one in January to one million/day in August 2020.

On Tuesday (25), the ministry informed that there has been more than 100 per cent hike in the recoveries in the last 25 days.

Delhi chief minister Arvind Kejriwal has on Wednesday (26) called a review meeting to discuss the coronavirus situation in the national capital.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weight loss pill

Foundayo is the latest GLP-1 treatment to receive UK approval in tablet form

Representational image: iStock

UK becomes first European nation to approve new weight-loss pill, but NHS access is still pending

  • The UK is the first European country to approve Eli Lilly’s Foundayo pill.
  • The tablet is taken once a day without food or water restrictions.
  • NHS availability will depend on a separate NICE assessment.

The UK has become the first European nation to approve a new daily weight-loss pill, giving patients another option beyond the injectable treatments that have dominated the GLP-1 market.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s orforglipron, sold under the brand name Foundayo, on August 10 for weight management and to improve blood sugar control in adults with type 2 diabetes.

Keep ReadingShow less